Cresco Labs (CRLBF) Accounts Payables (2019 - 2026)

Cresco Labs has reported Accounts Payables for 8 years, with the latest figure at $14.2 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables changed N/A year-over-year to $14.2 million; the trailing twelve-month figure through Mar 2026 stood at $14.2 million (changed N/A YoY), and the FY2025 full-year result was $16.5 million, changed N/A from the prior year.
• Accounts Payables for Q1 2026 stood at $14.2 million, down from $16.5 million in the prior quarter.
• The five-year high for Accounts Payables was $33.3 million in Q1 2022, with the low at -$392000.0 in Q2 2022.
• Historically, Accounts Payables has averaged $20.7 million across 5 years, with a median of $19.0 million in 2024.
• Annual changes were most pronounced in 2022 — Accounts Payables plunged 102.9% — and 2023, when it soared 8147.96%.
• Cresco Labs' Accounts Payables stood at $29.2 million in 2022, then retreated by 5.5% to $27.6 million in 2023, then slumped by 30.57% to $19.2 million in 2024, then decreased by 13.65% to $16.5 million in 2025, then slipped by 14.31% to $14.2 million in 2026.
• The last three Accounts Payables figures came in at $14.2 million (Q1 2026), $16.5 million (Q4 2025), and $19.2 million (Q3 2024), per Business Quant data.